Cytochalasin B

Suppliers

Names

[ CAS No. ]:
14930-96-2

[ Name ]:
Cytochalasin B

[Synonym ]:
EINECS 239-000-2
2H-Oxacyclotetradecino[2,3-d]isoindole-2,18(5H)-dione, 6,7,8,9,10,12a,13,14,15,15a,16,17-dodecahydro-5,13-dihydroxy-9,15-dimethyl-14-methylene-16-(phenylmethyl)-, (3E,5R,9R,11E,12aS,13S,15S,15aS,16S,18aS)-
(3E,5R,9R,11E,12aS,13S,15S,15aS,16S,18aS)-16-Benzyl-5,13-dihydroxy-9,15-dimethyl-14-methylene-6,7,8,9,10,12a,13,14,15,15a,16,17-dodecahydro-2H-oxacyclotetradecino[2,3-d]isoindole-2,18(5H)-dione
Phomin
(3E,5R,9R,11E,12aS,13S,15S,15aS,16S,18aS)-16-benzyl-5,13-dihydroxy-9,15-dimethyl-14-methylidene-6,7,8,9,10,12a,13,14,15,15a,16,17-dodecahydro-2H-oxacyclotetradecino[2,3-d]isoindole-2,18(5H)-dione
Cytochalasin B
MFCD00077704

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
740.6±60.0 °C at 760 mmHg

[ Melting Point ]:
218-223ºC

[ Molecular Formula ]:
C29H37NO5

[ Molecular Weight ]:
479.608

[ Flash Point ]:
401.7±32.9 °C

[ Exact Mass ]:
479.267181

[ PSA ]:
95.86000

[ LogP ]:
3.71

[ Vapour Pressure ]:
0.0±2.6 mmHg at 25°C

[ Index of Refraction ]:
1.596

[ Storage condition ]:
−20°C

[ Water Solubility ]:
ethanol: 20 mg/mL

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
RO0205000
CHEMICAL NAME :
2H-Oxacyclotetradec(2,3-d)isoindole-2,18(5H)-dione, 16-benzyl-6,7,8,9,10,12a,13,14,15,15a, 16,17-dodecahydro-5,13-dihydroxy-9,15-dimethyl-14-met hylene-, (E)-(5S,9R,12aS,13S,15S,15aS, 16aS,18aS)-
CAS REGISTRY NUMBER :
14930-96-2
LAST UPDATED :
199612
DATA ITEMS CITED :
18
MOLECULAR FORMULA :
C29-H37-N-O5
MOLECULAR WEIGHT :
479.67
WISWESSER LINE NOTATION :
T56-14- 1A U AXVM GY TVO JU RUTJ D1R& F1 GU1 HQ M1 QQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
11 mg/kg
TOXIC EFFECTS :
Behavioral - ataxia Behavioral - coma Lungs, Thorax, or Respiration - cyanosis
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
30 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1500 ug/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
5 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - Central Nervous System

MUTATION DATA

TYPE OF TEST :
Cytogenetic analysis
TEST SYSTEM :
Mammal - species unspecified Bone marrow
DOSE/DURATION :
1 gm/L
REFERENCE :
TSITAQ Tsitologiya. Cytology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1959- Volume(issue)/page/year: 24,814,1982

Safety Information

[ Symbol ]:

GHS06

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H302-H330

[ Precautionary Statements ]:
P260-P284-P310

[ Personal Protective Equipment ]:
Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ Hazard Codes ]:
T+: Very toxic;

[ Risk Phrases ]:
R26/27/28;R63

[ Safety Phrases ]:
28-36/37-45

[ RIDADR ]:
UN 1544 6

[ WGK Germany ]:
3

[ RTECS ]:
RO0205000

[ Packaging Group ]:
I

[ Hazard Class ]:
6.1(a)

[ HS Code ]:
29349990

Synthetic Route

Precursor & DownStream

Precursor

  • (3E,5R,9S,11E,12aS,15S,15aS,16S,18aR)-16-benzyl-5-((tert-butyldimethylsilyl)oxy)-9,14,15-trimethyl-6,7,8,9,10,12a,15,15a,16,17-decahydro-2H-[1]oxacyclotetradecino[2,3-d]isoindole-2,18(5H)-dione
  • (3E,5R,9S,11E,12aS,15S,15aS,16S,18aR)-17-acetyl-16-benzyl-5-((tert-butyldimethylsilyl)oxy)-9,14,15-trimethyl-6,7,8,9,10,12a,15,15a,16,17-decahydro-2H-[1]oxacyclotetradecino[2,3-d]isoindole-2,18(5H)-dione
  • (3S,3aS,4R,6aR,10S,14R,18aR,E)-3-benzyl-14-((tert-butyldimethylsilyl)oxy)-4,5,10-trimethyl-3,3a,4,6a,9,10,11,12,13,14,15,16-dodecahydro-1H-[1]oxacyclotetradecino[2,3-d]isoindole-1,17(2H)-dione
  • (3S,3aS,10S,14R,18aR,E)-2-acetyl-3-benzyl-14-((tert-butyldimethylsilyl)oxy)-4,5,10-trimethyl-3,3a,4,6a,9,10,11,12,13,14,15,16-dodecahydro-1H-[1]oxacyclotetradecino[2,3-d]isoindole-1,17(2H)-dione
  • (1E,4S,8R,9E,12aS,15S,15aS,16S,16aR,17aS,17bS)-14-acetyl-15-benzyl-8-((tert-butyldimethylsilyl)oxy)-4,16,16a-trimethyl-3,5,6,7,8,14,15,15a,16,16a,17a,17b-dodecahydro-11H-[1]oxacyclotetradecino[2,3-d]oxireno[2,3-f]isoindole-11,13(4H)-dione

DownStream

  • Cytochalasin A

Articles

Crystal structure of a glucose/H+ symporter and its mechanism of action.

Proc. Natl. Acad. Sci. U. S. A. 110(44) , 17862-7, (2013)

Glucose transporters are required to bring glucose into cells, where it is an essential energy source and precursor in protein and lipid synthesis. These transporters are involved in important common ...

Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

J. Med. Chem. 51 , 6740-51, (2008)

The work provides a new model for the prediction of the MAO-A and -B inhibitor activity by the use of combined complex networks and QSAR methodologies. On the basis of the obtained model, we prepared ...

Discovery of the migrasome, an organelle mediating release of cytoplasmic contents during cell migration.

Cell Res. 25(1) , 24-38, (2015)

Cells communicate with each other through secreting and releasing proteins and vesicles. Many cells can migrate. In this study, we report the discovery of migracytosis, a cell migration-dependent mech...


More Articles


Related Compounds

  • Dihydrocytochalasin B
  • 2,3-Dihydro-cytochalasin B
  • 7,20-O,O'-diacetyl-cytochalasin B
  • (16R,20R)-7β,9,20-trihydroxy-16-methyl-1-oxo-10-phenyl-9,23-seco-[13]cytochalasa-6(12),13t,21t-trien-23-oic acid
  • cytochalasin H(2)B
  • cytochalasin
  • 2-(4-fluorophenyl)-1-((5R,8S)-6,7,8,9-tetrahydro-5H-5,8-epiminocyclohepta[d]pyrimidin-10-yl)ethanone
  • N-(3-fluorophenyl)-2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)-1,3-dioxo-3,5,6,7,8,9-hexahydropyrimido[1,6-a]azepin-2(1H)-yl]acetamide
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 2-chloro-4-[(3S)-3-hydroxybutyl]phenol
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde